Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor in Stable Ischemic Heart Disease with Elevated Troponin
2015-001574-18Phase 2Terminated
- Sponsor
- AUSL Romagna
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ticagrelor in coronary arteriosclerosis, sponsored by AUSL Romagna. Primary endpoint: Change in mean hsTnT concentration. Started May 2021; status: terminated.
02
Drugs
ticagrelor
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2015-001574-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001574-18.